Lioness Medtech
Private Company
Total funding raised: $1.2M
Overview
Lioness Medtech is a Stockholm-based commercial-stage company operating as a specialized distributor and service provider for high-end oncology and radiology technologies. It holds key distribution agreements for major manufacturers like Sumitomo Heavy Industries (proton therapy, cyclotrons), ZAP Surgical (ZAP-X radiosurgery), Hyperfine (portable MRI), and Brightonix Imaging (PET scanners), positioning itself as a one-stop shop for advanced cancer centers. The company focuses on integrating these premier tools to enable state-of-the-art particle therapy projects and diagnostic workflows, aiming to improve clinical outcomes through better imaging and more precise radiation delivery. Its business model is built on sales, service, and support for complex medical capital equipment.
Technology Platform
Integrated commercial and service platform for distributing and supporting advanced medical devices in radiotherapy (proton therapy, stereotactic radiosurgery, BNCT), nuclear medicine (cyclotrons, PET), and portable imaging (MRI). Acts as a value-added integrator of best-in-class partner technologies.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Lioness Medtech competes with large, global medical device distributors (e.g., Siemens Healthineers, Elekta, Varian have direct sales) and other regional specialty distributors. Its differentiation lies in its focused expertise in particle therapy and its curated portfolio of niche, best-in-class technologies. It must continually demonstrate superior integration and service capabilities to defend its position.